RYM

NASagrify($RYM) CEO Buys Again While Executives Sell: Mixed Insider Signals Fuel Volatility Surge

09/22/2025 21:30

NASagrify ($RYM) CEO Benjamin Kovler made two notable purchases in September at around $37-40 levels, signaling strong management confidence. This marks his second buying spree following a November 2024 purchase at $45.17 during a sharp price rally, suggesting he views current levels as undervalued. The cannabis and hemp technology specialist rebranded from Agrify Corp to NASagrify in August 2025, positioning for a new growth phase. The company operates a unique integrated business model combining branded consumer products like RYTHM and incredibles with extraction equipment across the U.S. and Canada. Its hemp-derived THC beverage brand 'Senorita' has gained distribution in thousands of retail locations including Total Wine and ABC Fine Wine & Spirits. However, contrasting with the CEO's aggressive buying, other executives have consistently sold shares throughout 2025, revealing internal perspective differences. In late May, directors Timothy Mahoney and Max Holtzman sold substantial positions around $24-25, while CSO David Kessler offloaded about $530,000 worth at $38.92 in December 2024. Interestingly, major shareholder RSLGH LLC purchased 32.3 million shares at $25-26 during the same period, showing opposite sentiment. $RYM has exhibited extreme volatility, trading from $4 levels in June 2024 to over $60 in November, then correcting to the $20s early this year before spiking again to $47 in late August. Currently trading around $40, this dramatic price action reflects a beta of 9.97 - roughly 10 times more volatile than the broader market. Financially, the company is undergoing a turnaround story. While revenue plummeted from $258 million in 2022 to $9.68 million in 2024, debt was dramatically reduced from $729 million to just $10.5 million over the same period. With $40.96 million in cash, the company maintains adequate liquidity for restructuring efforts, though it still posts annual net losses of $37.8 million. At a market cap of $79.9 million, the stock trades at 11.99x sales - reflecting high growth expectations typical of cannabis sector speculation. As regulatory easing and hemp beverage market expansion gain momentum, speculative demand has driven valuations, but translation to actual business results remains the key variable. Amid 2025's record small-cap rally with the Russell 2000 reaching new highs, high-volatility names like $RYM are attracting increased investor attention. Fed rate cut expectations combined with anticipated Trump administration deregulation have sparked renewed interest in overlooked small-cap opportunities. While the CEO's consecutive purchases signal optimism, the persistent executive selling and ongoing profitability challenges warrant cautious approach. Investors should closely monitor upcoming quarterly results for signs of revenue recovery or margin improvement.